<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9513551</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20288</journal-id>
<journal-id journal-id-type="nlm-ta">Psychiatry Clin Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Psychiatry Clin. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Psychiatry and clinical neurosciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">1323-1316</issn>
<issn pub-type="epub">1440-1819</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30864184</article-id>
<article-id pub-id-type="pmc">6625892</article-id>
<article-id pub-id-type="doi">10.1111/pcn.12839</article-id>
<article-id pub-id-type="manuscript">NIHMS1020671</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mapping causal pathways from genetics to neuropsychiatric disorders using genome-wide imaging genetics: current status and future directions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Le</surname>
<given-names>Brandon D.</given-names>
</name>
<degrees>M.S.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stein</surname>
<given-names>Jason L.</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Genetics &amp; UNC Neuroscience Center, University of North Carolina at Chapel Hill, USA</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Author contributions:</p>
<p id="P2">B.D.L. and J.L.S. drafted the manuscript.</p>
</fn>
<corresp id="CR1"><label>*</label>To whom correspondence should be addressed: Room 8109C, Neuroscience Research Building, 115 Mason Farm Rd, Chapel Hill, NC 27599-7250, USA, <email>jason_stein@med.unc.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P50">Disclosure Statement:</p>
<p id="P51">The authors declare no conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>29</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>7</month>
<year>2020</year>
</pub-date>
<volume>73</volume>
<issue>7</issue>
<fpage>357</fpage>
<lpage>369</lpage>
<!--elocation-id from pubmed: 10.1111/pcn.12839-->
<abstract id="ABS1">
<p id="P3">Imaging genetics aims to identify genetic variants associated with the structure and function of the human brain. Recently, collaborative consortia have been successful in this goal, identifying and replicating common genetic variants influencing gross human brain structure, as measured through MRI. In this review, we contextualize imaging genetic associations as one important link in understanding the causal chain from genetic variant to increased risk for neuropsychiatric disorders. We provide examples in other fields of how identifying genetic variant associations to disease and multiple phenotypes along the causal chain has revealed a mechanistic understanding of disease risk, with implications for how imaging genetics can be similarly applied. We discuss current findings in the imaging genetics research domain, including that common genetic variants can have a slightly larger effect on brain structure than on risk for disorders like schizophrenia, indicating a somewhat simpler genetic architecture. Also, gross brain structure measurements share a genetic basis with some, but not all, neuropsychiatric disorders, invalidating the previously held belief that they are broad endophenotypes, yet pinpointing brain regions likely involved in pathology of specific disorders. Finally, we suggest that in order to build a more detailed mechanistic understanding of the effects of genetic variants on the brain, future directions in imaging genetics research will require observations of cellular and synaptic structure in specific brain regions beyond the resolution of MRI. We expect that integrating genetic associations at biological levels from synapse to sulcus will reveal specific causal pathways impacting risk for neuropsychiatric disorders.</p>
</abstract>
<kwd-group>
<kwd>genome-wide association study</kwd>
<kwd>imaging genetics</kwd>
<kwd>neuropsychiatric disorders</kwd>
<kwd>tissue clearing</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>